Cytek Biosciences Insider Transactions: CFO Increases Holding by 169% in 2025.

Cytek Biosciences insiders were net buyers of the company's stock in the last year, with the largest purchase being by Chief Financial Officer William McCombe, who bought $97k worth of shares at $2.78 per share. Insiders own 9.3% of the company's shares, worth $60m. While the transactions are encouraging, they do not necessarily indicate a bullish outlook for the company.